Updates are available Correction dated 2017-10-23

Article History

Received: 27 April 2017

Accepted: 18 May 2017

First Online: 27 May 2017

Change Date: 23 October 2017

Change Type: Correction

Change Details: Correction to: J Cancer Res Clin Oncol (2017) 143:2059–2066 DOI 10.1007/s00432-017-2445-z

Compliance with ethical standards

:

: The authors declare the following relationships with pharmaceutical companies: Ariad—receipt of honoraria: (JLS, MTG-C, VG-G, GO, ARP, RV, AH, LFC-M,) and research funding (JLS, VG-G, AH, LFC-M,); Bristol-Myers-Squibb—receipt of honoraria (JLS, LFC-M,MTG-C, VG-G, GO, JL L-L, GB, AR-P,RV) and research funding (JLS, LFC-M); Novartis—receipt of honoraria (JLS, DC, MTG-C, VG-G, GO, AR-P, RV, JL L-L, AA-L, VC, GB, FG, AH, LFC-M) and research funding (JLS, VG-G, RV, JL L-L, AH, LFC-M); Pfizer—receipt of honoraria (JLS, MTG-C, VG-G, ARP, JL L-L, AH, LFC-M) and research funding (JLS, VG-G, AH, LFC-M). The following authors declare no relationship with any pharmaceutical companies: EO, FV-L,PG, EC, LP, LC